OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr | ₹-9.08 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹-9.59 Cr |
Mar2023 | ₹-7.89 Cr |
Mar2022 | ₹1.50 Cr |
Mar2021 | ₹-1.55 Cr |
Mar2020 | ₹-9.08 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹-9.59 Cr | Negative | |
Mar2023 | ₹-7.89 Cr | Negative | |
Mar2022 | ₹1.50 Cr | Positive | |
Mar2021 | ₹-1.55 Cr | Negative | |
Mar2020 | ₹-9.08 Cr | - |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹232.4 Cr | 7% | -10.3% | -31.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹398,218.0 Cr | -0.7% | 3% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,158.0 Cr | 1.9% | 8.3% | 5.8% | Stock Analytics | |
CIPLA | ₹126,710.0 Cr | 0.5% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,586.0 Cr | -0.1% | NA | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,496.0 Cr | -2% | -5.4% | -7.5% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 7% |
-10.3% |
-31.6% |
SENSEX | 1.6% |
2.1% |
2.6% |
You may also like the below Video Courses